EP Patent

EP3785540A1 — Polyisobutene for use in treatment or prevention of infection by arthropods

Assigned to Oystershell NV · Expires 2021-03-03 · 5y expired

What this patent protects

The present invention provides polyisobutene and composition thereof and their use medical, insecticidal, prophylactic or therapeutic substances for the treatment or prevention of infection or infestation by arthropods. More specifically, the invention relates to the use of polyi…

USPTO Abstract

The present invention provides polyisobutene and composition thereof and their use medical, insecticidal, prophylactic or therapeutic substances for the treatment or prevention of infection or infestation by arthropods. More specifically, the invention relates to the use of polyisobutene and compositions thereof for treatment of lice infections.

Drugs covered by this patent

Patent Metadata

Patent number
EP3785540A1
Jurisdiction
EP
Classification
Expires
2021-03-03
Drug substance claim
No
Drug product claim
No
Assignee
Oystershell NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.